In silico bioavailability for BCS class II efavirenz tablets using biorelevant dissolution media for IVIVR and simulation of formulation changes.
Drug Dev Ind Pharm
; 47(8): 1342-1352, 2021 Aug.
Article
in En
| MEDLINE
| ID: mdl-34622730
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Models, Biological
Type of study:
Prognostic_studies
Language:
En
Journal:
Drug Dev Ind Pharm
Year:
2021
Document type:
Article
Affiliation country:
Brazil